Farrow Financial »

Crispr Therapeutics shares owned by Farrow Financial

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Farrow Financial from 13F filings

Historical chart of Farrow Financial investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Farrow Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Farrow Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $932k 20k 46.98
2024-06-30 $938k 17k 54.01
2024-03-31 $1.2M 17k 68.16
2023-12-31 $1.2M 19k 62.60